FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for Mycophenolic acid filed by Biocon Pharma Inc., updating the labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Organ Transplant Rejection
• Systemic Lupus Erythematosus

Drugs mentioned

• Mycophenolic acid (mycophenolic acid)

Snippet

SUPPL AP for MYCOPHENOLIC ACID (MYCOPHENOLIC ACID)